SCYX
SCYX
NASDAQ · Pharmaceuticals

Scynexis Inc

$4.36
-0.10 (-2.24%)
Analyst Consensus
Strong Buy
9
Analysts
Moderate
Coverage
Buy 8 89%
Hold 1 11%
Sell 0 0%
Price Target
Analyst Price Target +86.2% upside
Low Target $6.66
Average Target $8.12
High Target $12.47
Current Price $4.36
Current
$4.36
Target
$8.12
$6.66 $8.12 avg $12.47
Scenario Analysis
Bear Case
$6.66
52.8%
Low target
Base Case
$8.12
+86.2%
Avg target
Bull Case
$12.47
+186.0%
High target
Risk/Reward
3.5x
Highly favorable
Price in Context
52-Week High
$9.20
-52.6% from high
52-Week Low
$3.53
+23.5% from low
Target vs 52W High
$8.12
-11.7% vs high
Peer Consensus — Pharmaceuticals
Stock Consensus Analysts Buy % Target Upside
LLY
Eli Lilly and Co.
Strong Buy 38 79% $1,330.33 +14.2%
RDY
Dr. Reddy's Laboratories
Strong Sell 45 31% +0.0%
JNJ
Johnson & Johnson
Buy 31 71% $299.55 +11.2%
MRK
Merck & Co. Inc.
Buy 36 72% $159.27 +6.5%
PFE
Pfizer Inc.
Hold 36 39% $33.90 +22.2%
BMY
Bristol-Myers Squibb Co
Hold 35 43% $174.50 +178.7%
RPRX
Royalty Pharma Plc- Cl A
Strong Buy 16 88% $36.26 -38.0%
ZTS
Zoetis Inc
Hold 24 50% $209.87 +194.2%